RankAlpha logo
Back to Rankings

RIGL

RigelA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
RIGL vs peer average
90/100
RIGL vs. peer average (A vs. C)
Grade spread
B 2 · C 2 · D 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

AURA is the first available peer comparator.

Loose same-sector, similar-market-cap biotechnology comparison; relevant mainly for clinical execution and pipeline optionality rather than Rigel's diversified commercial portfolio.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAURAAura Biosciences
RIGL
Rigel
AURA
Aura Biosciences
Grade
A
B
Momentum
94
48
Value
70
41
Sentiment
75
74
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs AURA

RIGL / AURA
Grade Position
Above peers
RIGL vs. peer average (A vs. C)
90/100
Momentum
94
RIGL
Value
70
RIGL
Sentiment
75
RIGL

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RIGL
1
AURA
AURA
B
80/100
+1
2
IMMX
IMMX
D
40/100
+3
3
DRUG
DRUG
C
60/100
+2
4
MNPR
Monopar Therapeutics Inc Common
B
80/100
+1
5
CYRX
CryoPort Inc Common
F
20/100
+4
AURA is the first peer returned for this comparison set.